Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

ALCLS:FP

30.9800 EUR 1.5400 4.74%

As of 11:35:00 ET on 04/01/2015.

Snapshot for Cellectis SA (ALCLS)

Open: 32.0000 Day's Range: 30.8000 - 32.4000 Volume: 200,043
Previous Close: 32.5200 52wk Range: 4.6200 - 40.7000 1-Yr Rtn: +351.60%

Stock Chart for ALCLS

No chart data available.
  • ALCLS:FP 30.9800
  • 1D
  • 1M
  • 1Y
32.5200
Interactive ALCLS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALCLS

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -0.0410
Est. EPS (EUR) (12/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 1,083.34
Shares Outstanding (M) 34.97
30 Day Average Volume 366,115
Price/Book (mrq) 129.7696
Price/Sale (ttm) 28.1355
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/04/2016
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALCLS

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ALCLS

Cellectis produces proteins for therapeutic purposes, researches improvements in seed characteristics, and develops treatments against single-gene disorders and against infections by DNA viruses.

Andre ChoulikaChairman/CEO/Co-FounderThierry MoulinChief Financial Officer
Mathieu SimonExec Vice PresidentPhilippe ValachsGeneral Secretary
More Company Profile & Key Executives for ALCLS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil